| Prev Close | 7.89 |
| Day Low/High | 7.99 / 8.68 |
| 52 Wk Low/High | 7.61 / 19.99 |
BioCryst Pharmaceuticals, Inc. (BCRX)
8.39
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 185.58B |
| Market Cap | 1.46B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers
The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.
Wait for the Pullback on BioCryst Pharmaceuticals
Prices are extended so don't go long just yet.
Everything We Know About BioCryst's New HAE Drug
BioCryst's Hereditary angioedema drug-trial results not compelling.
Big-Cap Tech Names, Biotechs, Oils Lifting Market
The number of new 12-month highs has climbed to 240.
Finally Getting Back to a Stock Picker's Market
The euphoria has calmed down, and if stocks can consolidate, we will have some better entry points.
Shark Bites: What, Market Worry?
Talk about Dow 20,000 is probably feeding off itself.
Valeant Stock Plunge Puts Focus on Chairman
Robert Ingram sits on four public company boards and is a director at three private companies, which governance experts view as cause for concern.
Midday Report: Chesapeake Energy Tanks; Stocks Extend Selloff
U.S. stocks picked up where they left off last week, extending a sharp selloff on Monday on worries over oil and disappointing earnings.
A Decent First Step
Does today's bounce means this little correction is ending?
Buy or Get Out of the Way
Market players are adding long exposure as the market runs away from them.
